YO-01027
CAS No. 209984-56-5
YO-01027 ( Dibenzazepine )
Catalog No. M13326 CAS No. 209984-56-5
YO-01027 (Dibenzazepine) is a dipeptidic γ-secretase inhibitor with IC50 of 2.6 nM and 2.9 nM for APPL and Notch cleavage, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 64 | In Stock |
|
| 5MG | 62 | In Stock |
|
| 10MG | 106 | In Stock |
|
| 25MG | 227 | In Stock |
|
| 50MG | 368 | In Stock |
|
| 100MG | 591 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameYO-01027
-
NoteResearch use only, not for human use.
-
Brief DescriptionYO-01027 (Dibenzazepine) is a dipeptidic γ-secretase inhibitor with IC50 of 2.6 nM and 2.9 nM for APPL and Notch cleavage, respectively.
-
DescriptionYO-01027 (Dibenzazepine) is a dipeptidic γ-secretase inhibitor with IC50 of 2.6 nM and 2.9 nM for APPL and Notch cleavage, respectively.
-
In VitroYO-01027 (0.25-10 μM, during 1-18 days) promotes iPSC generation from human neonatal keratinocytes.YO-01027 (2 μM, 3 days) does not affect p53 activity in OCT4, SOX2-transduced human keratinocytes.YO-01027 (10 μM, 3 days) promotes the proliferation of supporting cells (SCs) in cultured mouse cochleae.YO-01027 (10 μM, 3 days) generates new hair cell (HCs) and increases the HCs number in neonatal mouse cochleae.
-
In Vivo——
-
SynonymsDibenzazepine
-
PathwayNeuroscience
-
TargetGamma-secretase
-
Recptorγ secretase (APPL)| γ secretase(Notch)
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number209984-56-5
-
Formula Weight463.48
-
Molecular FormulaC26H23F2N3O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:92 mg/mL (198.49 mM); Ethanol:<1 mg/mL (<1 mM); Water:<1 mg/mL (<1 mM)
-
SMILESC[C@H](NC(CC1=CC(F)=CC(F)=C1)=O)C(N[C@@H]2C(N(C)C3=CC=CC=C3C4=CC=CC=C24)=O)=O
-
Chemical Name(S)-2-(2-(3,5-difluorophenyl)acetamido)-N-((S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)propanamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Groth C, et al, Mol Pharmacol, 2010, 77(4), 567-574.
molnova catalog
related products
-
Enoticumab
Enoticumab (REGN421) is a fully human IgG1 monoclonal antibody with anticancer activity that inhibits the growth of cancer cells.Enoticumab binds human Dll4 and disrupts Notch-mediated signaling.
-
CIA-1 (Free base)
CIA-1 (Free base) is a nuclear receptor COUP-TFII inhibitor with IC50 values ranging from 1.2 μM to 7.6 μM in prostate cancer cell lines.
-
Aβ-IN-1
Aβ-IN-1 is a novel, potent and orally active γ-secretase modulator (GSM). Aβ-IN-1 potently reduced Aβ42 levels with an IC 50 value of 0.091 μM in cultured cells without inhibiting CYP3A4. Aβ-IN-1 shows a sustained pharmacokinetic profile.
Cart
sales@molnova.com